Combined analyses of the levels of white blood cells, lymphocytes, C-reactionprotein (CRP), and serum amyloid protein A can improve the specificity and sensitivity of COVID-19 diagnosis (25–27). This evidence concerns the gene SAA1 and COVID-19.